Genotipas

Genotipas is a leading medical and diagnostic laboratory dedicated to empowering health through advanced genetic insights and personalized diagnostics. With a commitment to innovation and science-driven solutions, Genotipas offers a comprehensive range of genetic and molecular testing services designed to provide accurate and actionable insights for individuals and healthcare professionals alike. Genotipas specializes in cancer testing, including hereditary cancer screening, non-invasive options like Colotect®, tumour genome profiling, and the prognostic breast cancer test Prosigna®. The company also provides drug efficacy testing (pharmacogenetics), nutrition and dermatology testing, anti-aging and athletic performance assessments, reproductive health and prenatal testing, neonatal and rare disease screening, and STD testing.

Genotipas is committed to simplifying complex science to deliver results that matter, ensuring trust and reliability. By offering a wide array of specialized tests such as NIFTY® and VISTA™ for prenatal care, NOVA™ for neonatal screening, and exome sequencing for rare mutations, Genotipas supports healthier and brighter futures for its clients. The company continues to expand its services, with ongoing developments and enhancements to meet the evolving needs of the medical community.

With a focus on personalized medicine, Genotipas continues to be a trusted partner in healthcare. The company strives to work collaboratively with patients and healthcare providers to achieve optimal health outcomes. We invite the manager of Genotipas to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative services and commitment to excellence.